Consumer - Retailing/Food & Drug Chains: Second
Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Consumer - Retailing/Food & Drug Chains: Second

SECOND TEAM Edward Kelly  Credit Suisse


Edward Kelly “has followed the companies so closely over the many years that he understands the nuances of what they are saying and going through — that’s what differentiates him from the pack,” proclaims one buy-side backer. The Credit Suisse analyst, who wins second place for a third year running, urged clients to buy Kroger Co. in December, at $20.40, on the belief that “sales and earnings would improve in 2011 as the industry stabilized, inflation and share gains accelerated and promotional discipline returned after a challenging period for the industry.” He was right. Last month the Cincinnati-based supermarket operator reported that year-over-year sales rose 11.5 percent, to $20.9 billion, in its second quarter, which ended August 13, and net income rose 7.3 percent, to $280.8 million. Kroger’s stock shot up 15.5 percent, to $23.56.


Gift this article